ArticleThe journal of pathology. Clinical research2021

PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways.

Shuyu Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.